| scholarly article | Q13442814 |
| P50 | author | Pavla Doležalová | Q58635420 |
| P2093 | author name string | Despina Eleftheriou | |
| Michael J Dillon | |||
| Paul A Brogan | |||
| Nigel Klein | |||
| Seza Ozen | |||
| Pat Woo | |||
| Kjell Tullus | |||
| Stephen D Marks | |||
| Clarissa Pilkington | |||
| Gavin Cleary | |||
| John Sills | |||
| Marianna Melo | |||
| P2860 | cites work | EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides | Q24675246 |
| Infliximab treatment for refractory Kawasaki syndrome | Q28174813 | ||
| Nomenclature of systemic vasculitides. Proposal of an international consensus conference | Q29616304 | ||
| Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis | Q33330958 | ||
| Etanercept plus standard therapy for Wegener's granulomatosis | Q33984596 | ||
| The use of immunosuppressive and cytotoxic drugs in non-malignant disease | Q34010757 | ||
| Vasculitis from the pediatric perspective | Q34109091 | ||
| How to induce remission in primary systemic vasculitis | Q36109386 | ||
| Vasculitis treatment - new therapeutic approaches | Q36416916 | ||
| Childhood vasculitis and plasma exchange | Q36568515 | ||
| EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis | Q36684589 | ||
| Clinical features and outcome of pediatric Wegener's granulomatosis | Q36832438 | ||
| Small-vessel vasculitis: therapeutic management | Q36906003 | ||
| Infliximab for the treatment of intravenous immunoglobulin resistant Kawasaki disease complicated by coronary artery aneurysms: a case report | Q37107147 | ||
| Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial | Q37144563 | ||
| Endothelial and platelet microparticles in vasculitis of the young. | Q40538261 | ||
| A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies | Q42163521 | ||
| Adalimumab: a new modality for Behçet's disease? | Q42844975 | ||
| Effectiveness of TNF-alpha blockade with infliximab in refractory Wegener's granulomatosis | Q43828598 | ||
| Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis | Q44419035 | ||
| Use of a cyclophosphamide-induction methotrexate-maintenance regimen for the treatment of Wegener’s granulomatosis: extended follow-up and rate of relapse | Q44427248 | ||
| Prospective study of TNFalpha blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis | Q44772811 | ||
| Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation | Q44810026 | ||
| Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis | Q45217518 | ||
| Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab | Q46504507 | ||
| Diagnostic role of endothelial microparticles in vasculitis. | Q53446731 | ||
| Anti-CD20 therapy of treatment-resistant Wegener's granulomatosis: favourable but temporary response. | Q53845558 | ||
| Juvenile polyarteritis: Results of a multicenter survey of 110 children | Q58429172 | ||
| P433 | issue | 8 | |
| P304 | page(s) | 978-986 | |
| P577 | publication date | 2009-06-17 | |
| P1433 | published in | Rheumatology | Q7320492 |
| P1476 | title | Biologic therapy in primary systemic vasculitis of the young | |
| P478 | volume | 48 |
| Q38888407 | A Case of Polyarteritis Nodosa Associated with Vertebral Artery Vasculitis Treated Successfully with Tocilizumab and Cyclophosphamide |
| Q38042828 | A case of refractory cutaneous polyarteritis nodosa in a patient with hepatitis B carrier status successfully treated with tumor necrosis factor alpha blockade |
| Q37722579 | ANCA-associated vasculitides-lessons from the adult literature. |
| Q59358441 | Adalimumab therapy in hepatitis B virus-negative polyarteritis nodosa: A case report |
| Q57612773 | Biologic targeted therapies in pediatric rheumatology |
| Q50010214 | Characteristics and outcome of intractable vasculitis syndrome in children: Nation-wide survey in Japan |
| Q36223700 | Coronavirus E protein forms ion channels with functionally and structurally-involved membrane lipids. |
| Q35430724 | Cutaneous polyarteritis nodosa in childhood: a case report and review of the literature |
| Q33701425 | Etanercept induces remission of polyarteritis nodosa: a case report |
| Q37640836 | Experience with rituximab in the treatment of antineutrophil cytoplasmic antibody associated vasculitis |
| Q50950055 | Favourable renal survival in paediatric microscopic polyangiitis: efficacy of a novel treatment algorithm. |
| Q36172162 | Impaired function of endothelial progenitor cells in children with primary systemic vasculitis |
| Q38044851 | Indications for use and safety of rituximab in childhood renal diseases |
| Q37288106 | Infection-Related Death among Persons with Refractory Juvenile Idiopathic Arthritis. |
| Q45138053 | Late recovery of renal function by rituximab in a patient with Wegener's granulomatosis. |
| Q35147587 | Long- term outcome of paediatric patients with ANCA vasculitis |
| Q33564565 | Lung involvement in childhood onset granulomatosis with polyangiitis |
| Q24604335 | Medium-size-vessel vasculitis |
| Q42010069 | Optic Neuropathy Secondary to Polyarteritis Nodosa, Case Report, and Diagnostic Challenges |
| Q39072021 | Paediatric anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: an update on renal management. |
| Q38356731 | Partial response to anakinra in life-threatening Henoch-Schönlein purpura: case report |
| Q53346945 | Pediatric Vasculitis. |
| Q24625167 | Pediatric vasculitis |
| Q40238293 | Polyarteritis nodosa in childhood: recognition of early dermatologic signs may prevent morbidity. |
| Q38046208 | Recent understanding on diagnosis and management of central nervous system vasculitis in children |
| Q37879814 | Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis. |
| Q92236542 | Recurrent ruptured abdominal aneurysms in polyarteritis nodosa successfully treated with infliximab |
| Q46309653 | Refractory otitis media: an unusual presentation of childhood granulomatosis with polyangiitis |
| Q33726139 | Rituximab Efficacy during a Refractory Polyarteritis Nodosa Flare |
| Q84962839 | Rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis |
| Q37561994 | Role of adalimumab in the management of children and adolescents with juvenile idiopathic arthritis and other rheumatic conditions |
| Q59160690 | Serious musculoskeletal infections in children receiving anti-tumor necrosis factor-α therapy: a case series |
| Q35011056 | Small vessel vasculitis |
| Q38113544 | Systemic polyarteritis nodosa in the young: a single-center experience over thirty-two years |
| Q35135936 | The development and assessment of biological treatments for children |
| Q26750499 | Therapeutic advances in the treatment of vasculitis |
| Q47660588 | Treatment Options for Resistant Kawasaki Disease |
| Q48592090 | Unmet Needs in the Pathogenesis and Treatment of Vasculitides. |
| Q91741001 | Vasculitis: A Checklist to Approach and Treatment Update for Dermatologists |
| Q40201731 | Young male patient diagnosed with cutaneous polyarteritis nodosa successfully treated with etanercept |
| Q46897584 | Young male patient diagnosed with cutaneous polyarteritis nodosa successfully treated with etanercept |
Search more.